FRANKLIN LAKES, N.J.,
Oct. 3, 2018 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, today announced that Tom Polen will add the responsibility of chief
operating officer of BD, in addition to his current role as
president. Polen continues to report Vincent A. Forlenza, chairman and
CEO.
As president and chief operating officer, Polen will have
oversight of BD's three operating segments, its innovation and new
product development pipeline, and global operations for the
company, including all manufacturing facilities and supply chain
operations.
"Tom's promotion reflects his leadership role developing and
implementing BD's strategy and vision and aligning our businesses
under three strong segment leaders," said Forlenza. "Tom's priority
of driving innovation to create category leadership, as well as his
focus on integrating Bard and enhancing the customer experience,
will help guide our segments, R&D portfolio and global
operations as we continue to shape BD into a partner of choice for
the global health care industry."
Polen was appointed president of BD in April 2017. The company has not had a chief
operating officer role since 2016.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 65,000
employees have a passion and commitment to help improve patient
outcomes, improve the safety and efficiency of clinicians' care
delivery process, enable laboratory scientists to better diagnose
disease and advance researchers' capabilities to develop the next
generation of diagnostics and therapeutics. BD has a presence in
virtually every country and partners with organizations around the
world to address some of the most challenging global health issues.
By working in close collaboration with customers, BD can help
enhance outcomes, lower costs, increase efficiencies, improve
safety and expand access to health care. In 2017, BD welcomed C. R.
Bard and its products into the BD family. For more information on
BD, please visit bd.com.
Contacts:
|
|
Troy
Kirkpatrick
|
Monique N.
Dolecki
|
BD Public
Relations
|
BD Investor
Relations
|
201.847.5378
|
858.617.2361
|
troy.kirkpatrick@bd.com
|
Monique_Dolecki@bd.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/tom-polen-promoted-to-chief-operating-officer-of-bd-300723489.html
SOURCE BD (Becton, Dickinson and Company)